These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33153768)

  • 1. Methylation associated miR-1246 contributes to poor prognosis in gliomas treated with temozolomide.
    Wang H; Wu B; Wang J; Hu Y; Dai X; Ye L; Cheng H
    Clin Neurol Neurosurg; 2021 Jan; 200():106344. PubMed ID: 33153768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155-3p promotes glioma progression and temozolomide resistance by targeting Six1.
    Chen G; Chen Z; Zhao H
    J Cell Mol Med; 2020 May; 24(9):5363-5374. PubMed ID: 32220051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-16-5p is frequently down-regulated in astrocytic gliomas and modulates glioma cell proliferation, apoptosis and response to cytotoxic therapy.
    Krell A; Wolter M; Stojcheva N; Hertler C; Liesenberg F; Zapatka M; Weller M; Malzkorn B; Reifenberger G
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):441-458. PubMed ID: 30548945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of circular RNA CEP128 suppresses proliferation and improves cytotoxic efficacy of temozolomide in glioma cells by regulating miR-145-5p.
    Hua L; Huang L; Zhang X; Feng H; Shen B
    Neuroreport; 2019 Dec; 30(18):1231-1238. PubMed ID: 31599823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-1268a regulates ABCC1 expression to mediate temozolomide resistance in glioblastoma.
    Li Y; Liu Y; Ren J; Deng S; Yi G; Guo M; Shu S; Zhao L; Peng Y; Qi S
    J Neurooncol; 2018 Jul; 138(3):499-508. PubMed ID: 29876787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
    Han J; Chen Q
    Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
    Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
    Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
    [No Abstract]   [Full Text] [Related]  

  • 11. miR-149 rs2292832 C allele enhances the cytotoxic effect of temozolomide against glioma cells.
    Xu B; Luo X; Ning X; Luo J; Guo J; Liu Q; Ling G
    Neuroreport; 2020 Apr; 31(6):498-506. PubMed ID: 32243354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
    Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6621-6628. PubMed ID: 31378904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity.
    Zhang D; Dai D; Zhou M; Li Z; Wang C; Lu Y; Li Y; Wang J
    Cell Physiol Biochem; 2018; 51(6):2496-2508. PubMed ID: 30562739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
    Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
    Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1.
    Wang J; Sai K; Chen FR; Chen ZP
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):147-58. PubMed ID: 23645289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
    Ma S; Fu T; Zhao S; Gao M
    Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.